Dual Nav1.7/1.8 antisense oligonucleotide (Quiver Bioscience)

N/A

Report date: 2025/06/27 16:57:41
NME

Base Information

Drug NameDual Nav1.7/1.8 antisense oligonucleotide (Quiver Bioscience)
Drug Alias NameDual Nav1.7 / 1.8 (ASO)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSodium channel protein type IX alpha subunit inhibitorsSodium channel protein type X alpha subunit inhibitors
TargetsSodium channel protein type IX alpha subunitSodium channel protein type X alpha subunit
Therapy Area/IndicationsChronic Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuiver Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesQuiver Bioscience Inc
Inactive CompaniesN/A
Active IndicationsChronic Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A